Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion molecules.
Engineered MHC-peptide targets capable of inducing recognition by CTL may prove useful in designing vaccines for infectious disease and cancer. We tested whether peptides directly linked to beta2-microglobulin (beta2m) could complex with human HLA class I heavy chain, and could be recognized by huma...
Main Authors: | Tafuro, S, Meier, U, Dunbar, P, Jones, E, Layton, G, Hunter, MG, Bell, J, Mcmichael, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
Genetic modulation of antigen presentation by HLA-B27 molecules.
by: Pazmany, L, et al.
Published: (1992) -
Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes.
by: Toshitani, K, et al.
Published: (1996) -
Isolation of a human allo-peptide presented by HLA-B51 molecules.
by: Tomiyama, H, et al.
Published: (1995) -
Evidence of widespread binding of HLA class I molecules to peptides.
by: Frelinger, J, et al.
Published: (1990) -
Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide.
by: Moss, P, et al.
Published: (1991)